All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Dibnepan Capsule
Salt Composition : Palmitoylethanolamide,diacerein,biochanin A
Manufacturer : BIOKINDLE LIFESCIENCES PVT LTD
Origin of Medicine : India
10 Capsule(s) In A Strip
Introduction to Dibnepan Capsule
Dibnepan Capsule is a health supplement containing the active ingredient palmitoylethanolamide + diacerein + biochanin A. This medication treats chronic kidney disease (CKD) and diabetic peripheral neuropathy. Chronic kidney disease (CKD) is a progressive and long-term medical condition in which the kidneys gradually lose their ability to function effectively over time which leads to the accumulation of waste products, excess fluids, and electrolyte imbalances in the body. Diabetic peripheral neuropathy (DPN) is a type of nerve damage that occurs as a complication of diabetes mellitus. It affects the peripheral nerves outside the brain and spinal cord.
Dibnepan Capsule is contraindicated in individuals with known hypersensitivity or allergy to it or its component. The main component in this capsule is palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide with anti-inflammatory and analgesic properties. It interacts with the endocannabinoid system and is studied for its potential to alleviate chronic pain and inflammation. Diacerein is a medication used to treat osteoarthritis. It inhibits certain enzymes involved in cartilage breakdown, helping manage symptoms and potentially slowing down the progression of osteoarthritis. Biochanin A is a natural isoflavone found in plants like red clover and soybeans. It's known for estrogenic effects and helps promote health and manage hormone-related conditions. Report to your doctor if you are pregnant, suspecting, or planning for the pregnancy before starting the treatment. Please consult with your doctor for more advice before breastfeeding your baby.
Uses of Dibnepan Capsule
- Treatment of chronic kidney disease
- Diabetic peripheral neuropathy
Therapeutic Effects of Dibnepan Capsule
Dibnepan Capsule is known for its anti-inflammatory and analgesic properties. It interacts with the endocannabinoid system and other pathways to reduce inflammation and modulate pain signals. This drug helps to alleviate the neuropathic pain associated with diabetes and relieves pain.
Interaction of Dibnepan Capsule with other drugs
Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Dibnepan Capsule and reduce effectiveness by causing undesirable side effects.
More Information about Dibnepan Capsule
- Store Dibnepan Capsule in a cool, dry, and dark place
- Protect from light and moisture.
How to consume Dibnepan Capsule
Take the Dibnepan Capsule as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the capsule if your doctor advises you to stop.
Safety Advices for Dibnepan Capsule
Pregnancy
If you are pregnant, suspecting, or planning for the pregnancy, report to your doctor before starting the treatment with Dibnepan Capsule.
Breast Feeding
Report to your doctor if you are breastfeeding before starting the Dibnepan Capsule treatment.
Lungs
It is unknown whether Dibnepan Capsule is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.
Liver
It is unknown whether the Dibnepan Capsule is safe for patients with liver problems. Inform your doctor if you have liver disease before starting the treatment.
Alcohol
It is unknown whether consuming alcohol interacts with the Dibnepan Capsule. Please consult your doctor for more advice.
Driving
Dibnepan Capsule does not affect your ability to drive or operate heavy machinery.
Side Effects of Dibnepan Capsule
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Dibnepan Capsule is generally safe to consume and is not associated with significant side effects. However, consult your physician for more advice if you experience any unfamiliar side effects.
Word of Advice
Tell your doctor immediately about all the medications you have been taking recently, including herbal and supplements, before taking Dibnepan Capsule. If you forget to take this medicine for the entire day, take your usual dose the next day. However, do not double-dose yourself. Throw away medicines that are no longer needed or are out-of-date. Keep medicines away from children and pets. Do not store these medicines in a damp place such as a bathroom, cabinet, or near the kitchen sink.
FAQs
Q 1. Are there any side effects associated with Dibnepan Capsule?
Dibnepan Capsule is generally considered safe and well-tolerated. However, some individuals may experience mild side effects such as stomach upset or allergic reactions.
Q 2. Can Dibnepan Capsule be used during pregnancy or breastfeeding?
Diacerein is not recommended during pregnancy or breastfeeding, as its safety in these situations has not been established.
Q 3. How should Dibnepan Capsule be taken?
The dosage and administration of Dibnepan Capsule will vary depending on the individual and the specific condition being treated. It is taken orally as a capsule with or without food, as directed by your physician. It's important to follow the prescribed dosage and schedule closely.
Fact Box of Dibnepan Capsule
Molecule name: Palmitoylethanolamide + Diacerein + Biochanin A
| Therapeutic class: Health supplement |
Pharmacological class: Supplements | Indications: 1. Treatment of chronic kidney disease 2. Diabetic peripheral neuropathy |
References
- Dibnepan, Biokindle [Accessed on 9th August 2023] https://www.biokindle.com/products-biokindle/dibnepan/
- Gabrielsson, L., Mattsson, S. and Fowler, C.J. (2016) Palmitoylethanolamide for the treatment of pain, Pharmacokinetics, safety and efficacy, British Journal of clinical pharmacology. [Accessed on 9th August 2023], https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094513/
- Lang-Illievich, K. et al. (2023) Palmitoylethanolamide in the treatment of chronic pain: A systematic review and meta-analysis of double-blind randomized controlled trials, MDPI. [Accessed on 9th August 2023], https://www.mdpi.com/2072-6643/15/6/1350
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
